Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates

The development of virus-like particle (VLP) based vaccines for human papillomavirus, hepatitis B and hepatitis E viruses represented a breakthrough in vaccine development. However, for dengue and COVID-19, technical complications, such as an incomplete understanding of the requirements for protecti...

Full description

Bibliographic Details

Published in:	Frontiers in Microbiology
Main Authors:	Simon Collett, Linda Earnest, Julio Carrera Montoya, Melissa A. Edeling, Ashley Yap, Chinn Yi Wong, Dale Christiansen, Jason Roberts, Jamie Mumford, Valerie Lecouturier, Vincent Pavot, Sergio Marco, Joon Keit Loi, Cameron Simmons, Shivali A. Gulab, Jason M. Mackenzie, Aaron Elbourne, Paul A. Ramsland, Garth Cameron, Dhiraj Hans, Dale I. Godfrey, Joseph Torresi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Subjects:	flavivirus arbovirus adjuvant VLP immunology SARS-CoV-2
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2023.1065609/full